Tapewire

NYSE · USD

BMY

BRISTOL MYERS SQUIBB CO

Export transactions ↓
Tapewire entity
1662
SEC CIK
0000014272
Parsed reports
2,253

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Tax withholdingCommon Stock, $0.10 par value 1,475 $37.53 $55,356.75
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 10

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,336

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Tax withholdingCommon Stock, $0.10 par value 1,094 $37.53 $41,057.82
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 9

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,811

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Tax withholdingCommon Stock, $0.10 par value 909 $37.53 $34,114.77
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 8

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,905

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
OtherCommon Stock, $0.10 par value 267 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 7

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,814

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
OtherCommon Stock, $0.10 par value 874 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 6

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,547

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
OtherCommon Stock, $0.10 par value 1,089 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 5

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,673

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Exercise / conversionCommon Stock, $0.10 par value 1,769 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 4

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Exercise / conversionCommon Stock, $0.10 par value 1,930 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 3

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Exercise / conversionCommon Stock, $0.10 par value 2,475 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 2

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Caldarella Joseph CSVP & Controller
Exercise / conversionCommon Stock, $0.10 par value 14,634 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007230 · doc4.xml · nonDerivative · entry 1

Caldarella Joseph C · CIK 0001341069 · SVP & Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,410

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
OtherPerformance Shares · Derivative 288.827 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 21

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,524.827

Underlying: Common Stock, $0.10 par value · 288.827 shares

Expires 2015-03-31

F20 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015.

F21 · shares: Represents dividend equivalents earned under the 2012-2014 Long-Term Performance Award.

F20 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015.

F20 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
GrantPerformance Shares · Derivative 7,236 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 20

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,236

Underlying: Common Stock, $0.10 par value · 7,236 shares

Expires 2015-03-31

F18 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.

F19 · shares: Represents performance shares earned under the 2012-2014 Long-Term Performance Award.

F18 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.

F18 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
OtherPerformance Shares · Derivative 779.4267 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 19

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,306.4267

Underlying: Common Stock, $0.10 par value · 779.4267 shares

Expires 2014-03-31

F16 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.

F17 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award.

F16 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.

F16 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
GrantPerformance Shares · Derivative 8,808 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 18

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,527

Underlying: Common Stock, $0.10 par value · 8,808 shares

Expires 2014-03-31

F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.

F15 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award.

F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.

F14 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionPerformance Shares · Derivative 34,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 17

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 34,175 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award.

F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
OtherPerformance Shares · Derivative 1,311.1908 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 16

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,175

Underlying: Common Stock, $0.10 par value · 1,311.1908 shares

Expires not disclosed

F12 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.

F13 · shares: Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award.

F12 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.

F12 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
GrantPerformance Shares · Derivative 9,933 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 15

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,863.8092

Underlying: Common Stock, $0.10 par value · 9,933 shares

Expires not disclosed

F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F11 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award.

F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionMarket Share Units · Derivative 3,009 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 14

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,029

Underlying: Common Stock, $0.10 par value · 3,009 shares

Expires 2016-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionMarket Share Units · Derivative 4,130 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 13

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,537

Underlying: Common Stock, $0.10 par value · 4,130 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F2 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date.

F2 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date.

F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionMarket Share Units · Derivative 3,703 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · derivative · entry 12

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,667

Underlying: Common Stock, $0.10 par value · 3,703 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F3 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

F3 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Tax withholdingCommon Stock, $0.10 par value 16,577 $37.53 $622,134.81
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 11

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,922.292

F7 · shares: Shares withheld for payment of taxes upon distribution of the 2010-2012 Long-Term Performance Award.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Tax withholdingCommon Stock, $0.10 par value 2,299 $37.53 $86,281.47
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 10

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 196,499.292

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Tax withholdingCommon Stock, $0.10 par value 1,987 $37.53 $74,572.11
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 9

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,798.292

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Tax withholdingCommon Stock, $0.10 par value 1,276 $37.53 $47,888.28
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 8

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,785.292

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
OtherCommon Stock, $0.10 par value 416 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 7

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 202,061.292

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
OtherCommon Stock, $0.10 par value 1,630 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 6

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,645.292

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
OtherCommon Stock, $0.10 par value 2,040 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 5

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,015.292

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionCommon Stock, $0.10 par value 3,009 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 4

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 197,975.292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionCommon Stock, $0.10 par value 3,703 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 3

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,966.292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionCommon Stock, $0.10 par value 4,130 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 2

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 191,263.292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:40 UTC
Cuss Francis MSVP Research
Exercise / conversionCommon Stock, $0.10 par value 34,175 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007231 · doc4.xml · nonDerivative · entry 1

Cuss Francis M · CIK 0001490216 · SVP Research

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,133.292

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
OtherPerformance Shares · Derivative 288.827 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 21

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,524.827

Underlying: Common Stock, $0.10 par value · 288.827 shares

Expires 2015-03-31

F20 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015.

F21 · shares: Represents dividend equivalents earned under the 2012-2014 Long-Term Performance Award.

F20 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015.

F20 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2015.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
GrantPerformance Shares · Derivative 7,236 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 20

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,236

Underlying: Common Stock, $0.10 par value · 7,236 shares

Expires 2015-03-31

F18 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.

F19 · shares: Represents performance shares earned under the 2012-2014 Long-Term Performance Award.

F18 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.

F18 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2015.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
OtherPerformance Shares · Derivative 779.4267 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 19

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,306.4267

Underlying: Common Stock, $0.10 par value · 779.4267 shares

Expires 2014-03-31

F16 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.

F17 · shares: Represents dividend equivalents earned under the 2011-2013 Long-Term Performance Award.

F16 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.

F16 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2014.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
GrantPerformance Shares · Derivative 8,808 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 18

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,527

Underlying: Common Stock, $0.10 par value · 8,808 shares

Expires 2014-03-31

F14 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.

F15 · shares: Represents performance shares earned under the 2011-2013 Long-Term Performance Award.

F14 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.

F14 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2014.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Exercise / conversionPerformance Shares · Derivative 31,546 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 17

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, $0.10 par value · 31,546 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F1 · shares: Represents distribution of performance shares earned under the 2010-2012 Long-Term Performance Award.

F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
OtherPerformance Shares · Derivative 1,208.7713 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 16

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,546

Underlying: Common Stock, $0.10 par value · 1,208.7713 shares

Expires not disclosed

F12 · derivative.exercise_price: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.

F13 · shares: Represents dividend equivalents earned under the 2010-2012 Long-Term Performance Award.

F12 · derivative.exercise_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.

F12 · derivative.expiration_date: Each dividend equivalent converts into one share of common stock upon distribution in the first quarter of 2013.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
GrantPerformance Shares · Derivative 9,168 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 15

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,337.2287

Underlying: Common Stock, $0.10 par value · 9,168 shares

Expires not disclosed

F10 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F11 · shares: Represents performance shares earned under the 2010-2012 Long-Term Performance Award.

F10 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

F10 · derivative.expiration_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2013.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Exercise / conversionMarket Share Units · Derivative 3,009 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 14

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,029

Underlying: Common Stock, $0.10 par value · 3,009 shares

Expires 2016-03-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

F4 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Exercise / conversionMarket Share Units · Derivative 3,812 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 13

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,219

Underlying: Common Stock, $0.10 par value · 3,812 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F2 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date.

F2 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 2, 2010. The balance of the award is scheduled to vest on the fourth anniversary of the grant date.

F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Exercise / conversionMarket Share Units · Derivative 3,703 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · derivative · entry 12

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,031

Underlying: Common Stock, $0.10 par value · 3,703 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%.

F3 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

F3 · derivative.expiration_date: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

F9 · balance_after: Represents an aggregate of the derivative securities beneficially owned under the awards granted on March 2, 2010 and March 1, 2011.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Tax withholdingCommon Stock, $0.10 par value 15,247 $37.53 $572,219.91
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 11

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 78,239.041

F7 · shares: Shares withheld for payment of taxes upon distribution of the 2010-2012 Long-Term Performance Award.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Tax withholdingCommon Stock, $0.10 par value 2,122 $37.53 $79,638.66
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 10

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,486.041

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Tax withholdingCommon Stock, $0.10 par value 1,987 $37.53 $74,572.11
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 9

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,608.041

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Tax withholdingCommon Stock, $0.10 par value 1,276 $37.53 $47,888.28
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 8

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,595.041

F6 · shares: Shares withheld for payment of taxes upon vesting of market share units.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
OtherCommon Stock, $0.10 par value 416 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 7

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,871.041

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
OtherCommon Stock, $0.10 par value 1,630 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 6

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,455.041

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
OtherCommon Stock, $0.10 par value 1,883 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 5

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,825.041

F5 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Exercise / conversionCommon Stock, $0.10 par value 3,009 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 4

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,942.041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: Represents vesting of one-quarter of market share units granted on March 6, 2012. The balance of the award is scheduled to vest in three equal installments on the second, third, and fourth anniversaries of the grant date.

Read SEC document
March 07, 2013 Filed Mar 11, 2013 20:43 UTC
DANIELS BRIANSVP Global Dev & Med Affairs
Exercise / conversionCommon Stock, $0.10 par value 3,703 $0.00 $0.00
Disclosure

SEC source: 0001225208-13-007232 · doc4.xml · nonDerivative · entry 3

DANIELS BRIAN · CIK 0001428698 · SVP Global Dev & Med Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 91,933.041

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents vesting of one-quarter of market share units granted on March 1, 2011. The balance of the award is scheduled to vest in two equal installments on the third and fourth anniversaries of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.